Teligent (TLGT)
(Delayed Data from NSDQ)
$0.17 USD
0.00 (0.00%)
Updated Oct 15, 2021 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Teligent, Inc. [TLGT]
Reports for Purchase
Showing records 41 - 53 ( 53 total )
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
4Q16 Recap - Strong 2017 Outlook Validates Business Model
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Resetting Expectations, but Growth Remains Robust
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Updated Model to Reflect Extended ANDA Timelines
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S